Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1988 1
1989 3
1990 6
1991 336
1992 872
1993 834
1994 1047
1995 850
1996 965
1997 832
1998 1104
1999 820
2000 773
2001 888
2002 741
2003 785
2004 819
2005 821
2006 699
2007 671
2008 677
2009 654
2010 690
2011 636
2012 577
2013 541
2014 548
2015 535
2016 476
2017 387
2018 365
2019 194
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

19,195 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Guidelines for the Use of Cyclosporine for Psoriasis: A Critical Appraisal and Comprehensive Review.
Soleymani T, et al. J Drugs Dermatol 2016 - Review. PMID 26954314
The purpose of this article is to review and compare the current evidence-based guideline recommendations for the use of cyclosporine in the treatment of psoriasis. Although the various guidelines are similar in their initial treatment recommendations, significant differences exist in recommendations on maximal treatment duration (1 year versus 2 years), intermittent short-term versus continuous therapy, use in erythrodermic and palmoplantar psoriasis, as well as recommendations on managing cyclosporine-associated side effects. ...
The purpose of this article is to review and compare the current evidence-based guideline recommendations for the use of cyclospor
Cyclosporine therapeutic window evaluation by Chebyshev's inequality method in kidney recipients.
Noreikaitė A, et al. Medicina (Kaunas) 2014. PMID 25060203 Free article.
OBJECTIVE: The aim of this study was to identify a cyclosporine therapeutic range for kidney recipients. MATERIALS AND METHODS: The cyclosporine exposure level was based on the calculation of the mean area under the concentration-time curve AUC(0-12). ...The therapeutic window of cyclosporine was calculated by the Chebyshev's inequality method with a 99% guarantee (α=0.01) using the IBM SPSS Statistics 20 software. ...
OBJECTIVE: The aim of this study was to identify a cyclosporine therapeutic range for kidney recipients. MATERIALS AND METHODS …
Ciclosporin and the cat: Current understanding and review of clinical use.
Colombo S and Sartori R. J Feline Med Surg 2018 - Review. PMID 29478396
Although the drug is currently only licensed to treat chronic allergic dermatitis in cats, a small number of reports describe its use in non-dermatological conditions. Evidence base: This article reviews the mechanism of action, pharmacokinetics, drug interactions, adverse effects and clinical use of CsA, both for the licensed indication and for off-label use in the feline patient. ...
Although the drug is currently only licensed to treat chronic allergic dermatitis in cats, a small number of reports describe its use
Allergic conjunctivitis: current concepts on pathogenesis and management
Sacchetti M, et al. J Biol Regul Homeost Agents 2018 - Review. PMID 29552874
Current treatments of AC include the use of antiallergic eye drops for mild forms, while recurrences of ocular surface inflammations with corneal involvement in severe forms require the use of topical steroids to avoid visual impairment. Novel steroid sparing therapies such as Cyclosporine A eye drops or topical Tacrolimus have been proposed to improve VKC and AKC management....
Current treatments of AC include the use of antiallergic eye drops for mild forms, while recurrences of ocular surface inflammations …
Use of cyclosporine in thoracic transplantation.
Zuckermann A and Klepetko W. Transplant Proc 2004 - Review. PMID 15041363
The use of cyclosporine (CyA) in clinical thoracic transplantation has markedly improved the survival and quality of life of patients in the past 2 decades. ...
The use of cyclosporine (CyA) in clinical thoracic transplantation has markedly improved the survival and quality of life of p …
Use of cyclosporine in lung transplantation.
Parekh K, et al. Transplant Proc 2004 - Review. PMID 15041361
Nephrotoxicity, hypertension, susceptibility to infections, and malignancy are some of the serious side effects of CsA that limit its therapeutic usefulness. ...CsA and tacrolimus seem to have equivalent results in lung transplantation, although a few patients may benefit from the use of tacrolimus....
Nephrotoxicity, hypertension, susceptibility to infections, and malignancy are some of the serious side effects of CsA that limit its the
Cyclosporine therapeutic and toxic effects may be related to different cyclosporine concentration zones in plasma.
Wu G and Yan SM. Med Hypotheses 2001. PMID 11388789
Different cyclosporine concentration zones can exist in plasma due to the temperature dependency in distribution and association, therefore cyclosporine therapeutic and toxic effects may partially be related to these concentration zones....
Different cyclosporine concentration zones can exist in plasma due to the temperature dependency in distribution and association, the …
Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?
Bulbul Baskan E and Yazici S. Cutan Ocul Toxicol 2018. PMID 28944688
OBJECTIVE: We assessed the efficacy and safety of methotrexate (MTX) and cyclosporine A (CsA) in the management of recalcitrant, extensive LPP and compared their efficacy and safety profile. ...
OBJECTIVE: We assessed the efficacy and safety of methotrexate (MTX) and cyclosporine A (CsA) in the management of recalcitrant, exte …
Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity.
Langford CA, et al. Ann Intern Med 1998 - Review. PMID 9653000
When cytotoxic agents were introduced, their ability to disrupt nucleic acid and protein synthesis led to their effective use for the treatment of neoplastic disease. ...As a result of these investigations, cytotoxic agents and, more recently, cyclosporine have emerged to become an important part of the therapeutic regimen for many autoimmune diseases. ...
When cytotoxic agents were introduced, their ability to disrupt nucleic acid and protein synthesis led to their effective use for the …
19,195 results
Jump to page
Feedback